Colon Cancer Stage III Clinical Trial
Official title:
A Prospectively Randomized Phase III Study on Adjuvant Chemotherapy and Adjuvant Chemo-Immunotherapy in Patients With Operated Colon Carcinoma Dukes C (Stage III; T1-4, N1-30, M0).
NCT number | NCT00309530 |
Other study ID # | ABCSG 90 |
Secondary ID | |
Status | Completed |
Phase | Phase 3 |
First received | March 31, 2006 |
Last updated | March 31, 2006 |
Start date | October 1990 |
This clinical investigation examined the effectivity 5-fluorouracil, of adding levamisol or interferon to 5-fluorouracil, and of a 5-fluorouracil/levamisol/interferon triple combination, in terms of recurrence-free and overall survival in curatively operable colon carcinoma Stage III.
Status | Completed |
Enrollment | 598 |
Est. completion date | |
Est. primary completion date | |
Accepts healthy volunteers | No |
Gender | Both |
Age group | 18 Years to 80 Years |
Eligibility |
Inclusion Criteria: - Patients with histologically verified, curatively operated colon carcinoma Stage III (R0, T1-4, N1-3, M0) - Age: less than 80 years - WHO Performace Status > 2 - Adequate bone marrow reserve - Informed consent Exclusion Criteria: - Rectal cancer - R1, R2, carcinosis peritonei - Start of chemo- or chemo-immunotherapy > 42 days postop; other adjuvant radiotherapy, chemotherapy or immunotherapy - Serious concomitant disease, in particular chronically inflammatory large intestine, cardiopathic disease, malignant second carcinoma |
Allocation: Randomized, Intervention Model: Factorial Assignment, Masking: Open Label, Primary Purpose: Treatment
Country | Name | City | State |
---|---|---|---|
Austria | State Hospital Feldkirch | Feldkirch | Vorarlberg |
Austria | Medical University of Graz, Oncology | Graz | Styria |
Austria | Hospital Guessing | Guessing | Burgenland |
Austria | State Hospital Kirchdorf | Kirchdorf | Upper Austria |
Austria | State Hospital Leoben, Surgery | Leoben | Styria |
Austria | General Hospital Linz | Linz | Upper Austria |
Austria | Hospital BHB Linz | Linz | Upper Austria |
Austria | Hospital Oberpullendorf | Oberpullendorf | Burgenland |
Austria | Paracelsus Medical University Salzburg - Oncology | Salzburg | |
Austria | Hospital BHB St. Veit/Glan, Surgery | St. Veit a. d. Glan | Carinthia |
Austria | Medical University Vienna, General Hospital | Vienna | |
Austria | Wilheminenspital, Internal Medicin I | Vienna | |
Austria | State Hospital Voecklabruck, Internal Medicine | Voecklabruck | Upper Austria |
Austria | Hospital Kreuzschwestern Wels | Wels | Upper Austria |
Austria | State Hospital Wolfsberg | Wolfsberg | Carinthia |
Austria | Hospital St. Vinzenz | Zams | Tyrol |
Lead Sponsor | Collaborator |
---|---|
Austrian Breast & Colorectal Cancer Study Group |
Austria,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Recurrence-free survival | |||
Primary | Overall survival |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT04907643 -
Virtual Reality for GI Cancer Pain to Improve Patient Reported Outcomes
|
N/A | |
Completed |
NCT04342676 -
Lymph Node Ratio and Kras Mutation in R Colon Cancer
|
Phase 3 | |
Enrolling by invitation |
NCT05179889 -
Adjuvant mFOLFIRINOX for High-risk Stage III Colon Cancer
|
Phase 2/Phase 3 | |
Withdrawn |
NCT05433402 -
Repurposing the Antipsychotic Drug Chlorpromazine as Adjuvant Therapeutic Agent for Resected Stage III Colon Cancer
|
Phase 1/Phase 2 | |
Recruiting |
NCT06108310 -
ArTificial inTelligence-based RAdiogenomics in Colon Tumors
|
||
Withdrawn |
NCT05310565 -
The Effects of Chiropractic in Adults With Colon Cancer
|
N/A | |
Not yet recruiting |
NCT04488159 -
Immunoscore as Decision Guidance for Adjuvant Chemotherapy in Colon Cancer
|
Phase 3 | |
Recruiting |
NCT05194878 -
Neoadjuvant FOLFOXIRI Versus Immediate Surgery for Stage II and III Colon Cancers
|
Phase 3 |